Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Autoregolazione cerebrale in chirurgia non cardiaca e relazione con lo stato di delirio postoperatorio (CERBERUS)

28 settembre 2026 aggiornato da: Samir Kendale, Beth Israel Deaconess Medical Center

Autoregolazione cerebrale in chirurgia non cardiaca e relazione con lo stato di delirio postoperatorio - Sperimentazione CERBERUS

The goal of this observational study is to learn the how to determine the mean arterial pressure(MAP) or blood pressure level to be maintained during non-cardiac surgery for optimal brain health in patients above the age of 60 undergoing major non-cardiac surgery. The main question[s] it aims to answer are:

  • Is there a way to tailor the blood pressure to be maintained in such patients during surgery for optimal brain health using non-invasive monitors that check the brains electrical activity, the electroencephalogram(EEG) monitor, and the brain's blood oxygen levels, the cerebral oximetry(CO) monitor?
  • How much does this optimal blood pressure level vary between patients?

Participants will be asked to:

  • Complete a questionnaire at the time they enroll into the study, as well as a daily questionnaire to help determine their level of thinking and brain health. This questionnaire will be administered by a member of the study team.
  • They will also have an EEG and CO monitoring sticker placed on their foreheads. This will be connected to a monitor that will collect this data just before, during, and after their surgery. The data collected through these monitors will help us with our study goals.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Study Procedures:

Pre-operative:

  1. Assessment by an anesthesiologist, and brief patient education about cerebral autoregulation and post-operative delirium.
  2. MOCA baseline cognitive assessment by study team member.

Intra-operative:

  1. Perioperative EEG Monitoring: EEG stickers will be applied to patient's forehead in pre-op holding area and attached to SedLine Root Monitor (described below in perioperative EEG and Cerebral Oximetry10 (CO) monitoring) at least 5 minutes prior to start of induction.

  2. Perioperative CO monitoring: NIRS stickers will be applied to patient's forehead in pre-op holding area and attached to SedLine Root Monitor (described below in perioperative EEG and Cerebral Oximetry (CO) monitoring) at least 5 minutes prior to start of induction.

  3. Live collection and processing of data: During surgery, the SedLine Root Monitor (which collects EEG & CO data) and the Operating Room's en-suite Phillips Intellivue monitor (which collects MAP data during surgery) will both be connected to a BIDMC-issued, IS-approved laptop or tablet running the ICM+ software suite. The SedLine Root Monitor and Philips Intellivue Monitor will output their data locally via cables to the system running the ICM+ software suite, which will process and integrate this data in real-time. This processed information will only be collected passively during the surgery, and will not inform or affect clinical care in any way.

    • Perioperative EEG and CO monitoring All patients will undergo EEG and CO monitoring during intraoperative, and possibly the postoperative period (up through 24 hours/until extubation, whichever occurs earlier). The EEG and CO leads will be removed from the patient and monitoring stopped at one of three end-points: a) 24 hours after the end of the surgical procedure b) at time of extubation c) when patient is shifted out of the PACU; whichever comes first. This is to ensure that comprehensive data on cerebral autoregulation during the critical perioperative period is available for any given patient for analysis. Electroencephalograms and CO will be recorded using the SedLine monitor (Masimo Corporation, Irvine California). SedLine is a FDA approved, patient-connected, 4-channel processed electroencephalograph EEG and Cerebral oximetry monitor designed specifically for intraoperative or intensive care use. It displays electrode status, EEG waveforms, Density Spectral Array (DSA) and bilateral regional cerebral oxygen saturation.

The SedLine EEG electrode array records approximately at positions Fp1, Fp2, F7, and F8, with reference approximately 1 cm above Fpz and ground at Fpz. The spectrograms will be computed using the Multitaper method from the unprocessed EEG signals recorded at a sampling frequency of 250 Hz. Individual spectra will be computed in 3-sec windows with 0.5 sec overlap between adjacent windows. Multitaper spectral estimates have near optimal statistical properties that substantially improve the clarity of spectral features.

The CO sensors are applied on the forehead.

  • EEG Display The EEG waveforms reflect electrical activity mostly from the front of the brain. The display is configured to contain 4 data input sources, acquired from the 4 sensor electrodes: L1, R1, L2, and R2.

Patient State Index (PSi)31,32 The PSi is a processed EEG parameter that is related to the effect of anesthetic agents, and takes into consideration, among other factors:

  1. changes in power in various EEG frequency bands
  2. changes in symmetry and synchronization between critical brain regions
  3. the inhibition of regions of the frontal cortex.

Density Spectral Array (DSA)31,32 The DSA contains left and right spectrograms representing the power of the EEG on both sides of the brain.

Multitaper DSA32 When using a Multitaper DSA, EEG data are transformed into the frequency domain, which may provide a better display of EEG features.

  • Post-operative:

Postoperative pain assessment

Postoperative pain will be assessed with a standard 11-point scale and by pain medication intake. Pain scores will be obtained by asking the subject and also collected from the medical record when documented clinically. Pain medication intake will be extracted from the medical record.

Delirium and cognition assessment Once consent is obtained, a trained research team member will proceed with baseline preoperative and postoperative cognitive, delirium, and depression assessments.

Baseline assessment

This will be conducted by study staff at the time of consent. If the patient cannot complete baseline assessment at time of consent, it may be conducted at a later time before surgery as per the patient's convenience on hospital premises. This will include the assessment of cognitive function using the:

  1. Montreal Cognitive Assessment (MoCA)11, supplemented with
  2. Days of the week (DOW) & Months of the year (MOY) for additional attention testing
  3. Delirium Symptom Interview (DSI) to capture symptoms of delirium
  4. Confusion Assessment Method (CAM)12,13: Using data from the cognitive testing and DSI, the researcher will complete the long CAM which includes the diagnosis of delirium using the CAM diagnostic algorithm.

These detailed assessments will take no more than 45 minutes. If this baseline assessment shows a MoCA score <10, the subject will be excluded from the study.

Postoperative assessment On each postoperative day during the hospital stay a research team member will administer a

  1. Standard cognitive assessment, including DOW, MOY, CAM, and DSI. These daily assessments will take approximately 10-15 minutes.
  2. If a subject is intubated postoperatively, a CAM-ICU will be performed instead of a CAM assessment.
  3. If a participant declines to complete a daily standard cognitive assessment, trial staff will offer the 3D-CAM as a shorter alternative. If the participant refuses both the daily standard cognitive assessments and the 3D-CAM, trial staff will use the CAM Only, a conversation-based method to score the CAM.
  4. If daily assessments have plateaued for 3 consecutive days (CAM negative each day), they will then only need to be completed every other day, as long as the subject remains CAM negative, until the date of discharge.
  5. In addition, medical charts will be reviewed every day until discharge or day 30 (whichever occurs first) to identify delirium. Any events related to delirium during the hospital stay and at the follow-up time points (1 month and 6 months) will be recorded on REDCap eCRF. Events such as trying to get out of bed, verbal abuse, falls, pulling tubes, inappropriate behavior during the hospital stay as noted in the medical charts will be recorded. At phone follow-up: prolonged rehabilitation, cognitive decline will be recorded.

Remote assessments After the patient consents to participate in the study and opts in for phone call assessments, the study team may use the t-MoCA as a substitute to the MoCA for remote assessment of baseline cognition. Additionally, for in-hospital assessments, study investigators may use the a-MoCA as a substitute to the MoCA if an inability for in-person visits arises. Sites may conduct substitution assessments via phone or site-specific HIPAA approved telemedicine video conferencing platform. The a-MoCA and the t-MoCA are identical assessments but differ in naming, where the term "a-MoCA" is used for in-person assessments, and the term "t-MoCA" is used for assessments conducted via phone. Both assessments exclude the visuoconstructional tests of alternating trails, drawing of cube and clock, and animal naming.

Discharge assessment On the day of discharge, the MoCA, with DOW and MOY, the CAM, and the DSI will be completed. (If the discharge assessment was performed in anticipation of discharge on a specific day but the discharge was delayed (i.e., logistical reasons, clinical reasons), this will not be considered a protocol deviation.) If the patient is discharged before a discharge assessment can be done, study staff may contact patient to administer t-MoCA along with DOW and MOY, CAM and DSI.

Follow-up assessment Follow-up assessments will be administered at 1 month (+14 days /- 7 days) and 6 months (+/- 30 days) after the date of surgery. These will be completed by a research team member via telephone and will include a telephone version of the MoCA (t-MoCA), with DOW and MOY, the CAM, SF-12, FRAIL scale, functional activity scale, and long term pain scale and the DSI. These assessments will be done at the patient's convenience and ability to finish the evaluations.

  • Delirium treatment The delirium research assessments will not be provided to the treating clinicians. Treating clinicians will assess and treat delirium per the standard of care.
  • Data Collection

Patient related information such as baseline characteristics including, comorbid conditions, medications, surgical and anesthetic data will be obtained from Society of Thoracic Surgery database, Anesthesia Information Management Systems and patient's medical record. EEG changes, waveforms and other related data will be recorded from the monitor. Additionally, to track other important factors related to outcome and protocol adherence, study investigators may extract clinical data from the medical record including, but not limited to:

  1. Anthropometric data (e.g. age, height, weight, race/ethnicity)
  2. Admission type
  3. Medications
  4. Pain scores
  5. Respiratory physiological data
  6. Hemodynamic data (e.g. heart rate, blood pressure)
  7. Laboratory data
  8. Complications data
  9. Hospitalization-related time data (e.g. admitting diagnosis, hospital and ICU length of stay)
  10. Vital status These data will be merged with subject cognitive assessment data. All data will be stored on password-protected computers, in locked file cabinets and/or offices, or REDCap.

Tipo di studio

Osservativo

Iscrizione (Stimato)

100

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

60 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Patients above the age of 60 scheduled to undergo major non-cardiac surgeries including but not limited to vascular, hepatobiliary, or complex spine surgeries requiring general anesthesia with arterial catheterization for monitoring.

Descrizione

Inclusion Criteria:

  • Age ≥ 60 years
  • Undergoing any non-cardiac surgeries including but not limited to vascular, hepatobiliary, or complex spine surgeries requiring general anesthesia with arterial catheterization for monitoring

Exclusion Criteria:

  1. Non-English speaking (Justification: cognitive assessment instruments are not validated in a sufficient range of languages, and the research team lacks polylingual capabilities or the financial resources to hire interpreters for the duration of all proposed assessments.)
  2. Cognitive impairment as defined by total MoCA score < 10 (justification: baseline cognitive dysfunction will confound primary outcome measure)
  3. Significant visual impairment (justification: will be difficult for patients to draw individual components in MOCA score)
  4. Emergent surgery (justification: insufficient time to initiate intervention)
  5. History of stroke within the last 3 months (justification: cognitive dysfunction secondary to stroke can confound outcome measures

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: CASE_ONLY
  • Prospettive temporali: PROSPECTIVE

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
Enrolled Participants

Patients above the age of 60 undergoing major non-cardiac surgery requiring invasive MAP monitoring as standard of care. They will be monitored intra-op using non-invasive EEG and CO monitors, which will be correlated with MAP.

They will also undergo baseline and followup assessment for post-operative delirium using the standardised CAM and MoCA tools administered by study staff.

Intra-op EEG and CO data will be collected non-invasively. This will not guide or affect patient care of procedure in any way.

Altri nomi:
  • Massimo SEDLINE Root Monitor

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
CA state and lower limits of autoregulation (LLA):
Lasso di tempo: 1 week

The primary outcome will be reliability in the form of an "uptime". This is a calculation of the percentage that each signal provides a feasible measurement, and a percentage that each method of autoregulation calculation produces an output.

Previous studies have demonstrated a high frequency of uptime, upwards of 90%. CA state and lower limits of autoregulation (LLA) will be calculated using two distinct methods, both previously published and enumerated in the Statistical Consideration section

1 week

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Duration of burst suppression in EEG
Lasso di tempo: 1 week

Determine the length of burst suppression on EEG monitoring for each patient. Burst suppression is defined as a period of isoelectric activity in the EEG waveforms.

1 week
Incidence of Postoperative Delirium (POD)
Lasso di tempo: Within 1 week

POD will be diagnosed by our trained research members based on the Confusion Assessment Method (CAM) algorithm postoperatively until discharge.

Within 1 week
Cognitive function
Lasso di tempo: 1 month and 6 months

Postoperative cognitive dysfunction at 1- and 6- months will be assessed with telephone version of the Montreal Cognitive Assessment (t-MoCA) with a maximum positive score of 22. The higher the score, the better the patient's cognitive function.

1 month and 6 months
Hemodynamic stability - Vasopressor Usage
Lasso di tempo: 1 week

Metrics of total vasopressor dose in norepinephrine equivalents

1 week
Hemodynamic stability - Time outside ideal systolic range
Lasso di tempo: 1 week

Time above/ below 90-130 mmHg systolic blood pressure in minutes

1 week
Hemodynamic stability - Area Under Curve
Lasso di tempo: 1 week

Area under the 65 mmHg mean arterial blood pressure curve in units of mmHg minutes

1 week
Hemodynamic stability - Coefficient of Variation recorded as a simple integer
Lasso di tempo: 1 week

Coefficient of variation of mean arterial blood pressure will be collected from the intraoperative record and medical records to be quantified and compared.

1 week

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

17 aprile 2024

Completamento primario (Stimato)

1 dicembre 2026

Completamento dello studio (Stimato)

1 luglio 2027

Date di iscrizione allo studio

Primo inviato

17 ottobre 2023

Primo inviato che soddisfa i criteri di controllo qualità

14 novembre 2023

Primo Inserito (Effettivo)

18 novembre 2023

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

30 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

28 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 2023-P-000843

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

Sì

prodotto fabbricato ed esportato dagli Stati Uniti

Sì

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .